FINECURE PHARMACEUTICALS LIMITED

Active    As on: 10 March, 2024    Update Info    Print    Share

OVERVIEW - FINECURE PHARMACEUTICALS LIMITED

Finecure Pharmaceuticals Limited is an unlisted public company incorporated on 18 March, 2005. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 20.00 cr and the total paid-up capital is INR 12.71 cr.

Finecure Pharmaceuticals Limited's operating revenues range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by -3.90 % over the previous year. At the same time, it's book networth has increased by 9.37 %. Other performance and liquidity ratios are available here.

Description: The company is engaged in manufacturing of health care, personal care and home care products.

Products & Services: Pre And Pro Biotics, Enzyme Preparations, Proteolytics, Anti-allergics Or Anti-cold, Cough- Suppressants, Hormones, Emergency Contraceptives, Anti- Haemorrhagics, Sayfur Cv Oral Dry Syrup, Sayfur Cv 500 Tablets, Sayfur Cv 250 Tablets, AZOM DRY SYRUP etc.
Category: Manufacturer

The current status of Finecure Pharmaceuticals Limited is - Active.

The last reported AGM (Annual General Meeting) of Finecure Pharmaceuticals Limited, per our records, was held on 30 September, 2023.

Finecure Pharmaceuticals Limited has six directors - Mukesh Tarachand Agarwal, Vivek Rajgarhia, and others.

The Corporate Identification Number (CIN) of Finecure Pharmaceuticals Limited is U24230GJ2005PLC045724. The registered office of Finecure Pharmaceuticals Limited is at A-1201, MONDEAL HEIGHTS, NR. WIDE ANGLE, S.G. HIGHWAY,, AHMEDABAD, Ahmedabad, Gujarat.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more

REGISTERED DETAILS - FINECURE PHARMACEUTICALS LIMITED


CIN

U24230GJ2005PLC045724

Incorporation Date / Age

18 March, 2005 / 19 yrs

Last Reported AGM Date

30 September, 2023


Authorized Capital

INR 2000.0 Lacs

Paidup Capital

INR 1270.865 Lacs

industry*

Manufacturing (Chemicals and chemical products)


type

Unlisted Public Company

category

Company limited by Shares

subcategory

Non-govt company


Email Address

Login for email address. This is to prevent spam.

Website

http://www.finecurepharma.com/. (Incorrect website?)

Registered Address

A-1201, MONDEAL HEIGHTS,
NR. WIDE ANGLE, S.G. HIGHWAY,
AHMEDABAD
Ahmedabad - 380015
Gujarat - India


How to download FINECURE PHARMACEUTICALS LIMITED report

A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.

FINECURE PHARMACEUTICALS LIMITED - Registration Details
CINU24230GJ2005PLC045724
Incorporation Date / Age18 March, 2005 / 19 yrs
Last Reported AGM Date30 September, 2023
Authorized CapitalINR 2000.0 Lacs
Paidup CapitalINR 1270.865 Lacs
industry*Manufacturing (Chemicals and chemical products)
typeUnlisted Public Company
categoryCompany limited by Shares
subcategoryNon-govt company
Email Address
Websitehttp://www.finecurepharma.com/
Registered AddressA-1201, MONDEAL HEIGHTS, NR. WIDE ANGLE, S.G. HIGHWAY, AHMEDABAD Ahmedabad - 380015 Gujarat - India

FINANCIAL HIGHLIGHTS - FINECURE PHARMACEUTICALS LIMITED

Provided here are the financial indicators for financial year ending on 31 March, 2023. Actual numbers and updated financial data are included in purchased financial report.
View Sample Report.
Operating Revenue INR 100 cr - 500 cr
EBITDA -3.90 %
Networth 9.37 %
Debt/Equity Ratio 0.32
Return on Equity 8.57 %

* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.

How to get financial reports of FINECURE PHARMACEUTICALS LIMITED

Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.

Directors - FINECURE PHARMACEUTICALS LIMITED

The company has 6 directors and 2 reported key management personnel.


The longest serving directors currently on board are Vivek Rajgarhia, Vishal Haremurari Rajgarhia and Vikash Rajgarhia who were appointed on 18 March, 2005. They have been on the board for more than 19 years. The most recently appointed director is Parshva Shashikant Jhaveri, who was appointed on 01 February, 2021.


Vivek Rajgarhia has the largest number of other directorships with a seat at a total of 4 companies. In total, the company is connected to 4 other companies through its directors.


NAME DESIGNATION APPOINTMENT DATE
MUKESH TARACHAND AGARWAL Director 21 December, 2017 Other directorships - KASHISH TEX PRIVATE LIMITED,  FINEBIOTICS PHARMA LIMITED, 
VIVEK RAJGARHIA Director 18 March, 2005 Other directorships - FINECURE FOUNDATION,  GLOBAL MEDISCIENCES LIMITED,  FINEBIOTICS PHARMA LIMITED, 
VISHAL HAREMURARI RAJGARHIA Director 18 March, 2005 Other directorships - FINECURE FOUNDATION,  GLOBAL MEDISCIENCES LIMITED, 
VIKASH RAJGARHIA Director 18 March, 2005 Other directorships - FINECURE FOUNDATION,  GLOBAL MEDISCIENCES LIMITED, 
PARSHVA SHASHIKANT JHAVERI Director 01 February, 2021 Other directorships - FINEBIOTICS PHARMA LIMITED, 
ANSHU KRISHNAKUMAR AGRAWAL Director 21 December, 2017 No other directorships
SONAMBEN VIJAYKUMAR ZATKIYA KMP 28 December, 2017 No other directorships
ASHISH SUBHASH CHANDRA SANGHVI KMP 28 December, 2017 No other directorships
NAME DESIGNATION APPOINTMENT DATE
MUKESH TARACHAND AGARWAL Director 21 December, 2017 View other directorships
VIVEK RAJGARHIA Director 18 March, 2005 View other directorships
VISHAL HAREMURARI RAJGARHIA Director 18 March, 2005 View other directorships
VIKASH RAJGARHIA Director 18 March, 2005 View other directorships
PARSHVA SHASHIKANT JHAVERI Director 01 February, 2021 View other directorships
ANSHU KRISHNAKUMAR AGRAWAL Director 21 December, 2017 No other directorships
SONAMBEN VIJAYKUMAR ZATKIYA KMP 28 December, 2017 No other directorships
ASHISH SUBHASH CHANDRA SANGHVI KMP 28 December, 2017 No other directorships
18 March, 2005

VIVEK RAJGARHIA

Director

18 March, 2005
18 March, 2005

VIKASH RAJGARHIA

Director

21 December, 2017
21 December, 2017
28 December, 2017

SONAMBEN VIJAYKUMAR ZATKIYA

KMP

28 December, 2017

ASHISH SUBHASH CHANDRA SANGHVI

KMP

01 February, 2021

Bank-wise Biggest Charges on Assets

See more...

Previous Names

No previous names were found for this company.

Previous CINs

No previous CINs were found for this company.

SIMILAR COMPANIES

NAME INCORPORATION YEAR STATE PAID UP CAPITAL
SUPREET CHEMICALS LIMITED It was formed in year 1992 in Gujarat . The company currently has a paid up capital of INR 12.70 cr.
1992 Gujarat 12.70 cr Buy financial reports
SOL PHARMACEUTICALS LTD It was formed in year 1983 in Telangana . The company currently has a paid up capital of INR 12.72 cr.
1983 Telangana 12.72 cr Buy financial reports
NB HEALTHCARE PRIVATE LIMITED It was formed in year 2019 in Gujarat . The company currently has a paid up capital of INR 12.70 cr.
2019 Gujarat 12.70 cr Buy financial reports
MEGI AGRO CHEM LIMITED It was formed in year 1999 in Maharashtra . The company currently has a paid up capital of INR 12.73 cr.
1999 Maharashtra 12.73 cr Buy financial reports
THE KUTCH SALT AND ALLIED INDUSTRIES LIMITED It was formed in year 1950 in Maharashtra . The company currently has a paid up capital of INR 12.67 cr.
1950 Maharashtra 12.67 cr Buy financial reports
VHB MEDI SCIENCES LIMITED It was formed in year 2007 in Maharashtra . The company currently has a paid up capital of INR 12.75 cr.
2007 Maharashtra 12.75 cr Buy financial reports
SCOTT EDIL PHARMACIA LIMITED It was formed in year 2003 in Chandigarh . The company currently has a paid up capital of INR 12.77 cr.
2003 Chandigarh 12.77 cr Buy financial reports
PONDY OXIDES AND CHEMICALS LIMITED It was formed in year 1995 in Tamil Nadu . The company currently has a paid up capital of INR 12.61 cr.
1995 Tamil Nadu 12.61 cr Buy financial reports
HYGENA LIFE SCIENCES PRIVATE LIMITED It was formed in year 2020 in Delhi . The company currently has a paid up capital of INR 12.60 cr.
2020 Delhi 12.60 cr Buy financial reports
SIONC PHARMACEUTICALS PRIVATE LIMITED It was formed in year 2008 in Andhra Pradesh . The company currently has a paid up capital of INR 12.58 cr.
2008 Andhra Pradesh 12.58 cr Buy financial reports

SUBSIDIARY COMPANIES

NAME STATE INCORPORATION YEAR PAID UP CAPITAL
Gujarat 2021 5.00 lac

Company Network - FINECURE PHARMACEUTICALS LIMITED

Company Network • Tofler Business Research Platform
How to use company network of FINECURE PHARMACEUTICALS LIMITED

Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.

FAQ - FINECURE PHARMACEUTICALS LIMITED

  • What is the Incorporation date of FINECURE PHARMACEUTICALS LIMITED?

    The Incorporation Date of FINECURE PHARMACEUTICALS LIMITED is 18 March, 2005.

  • What is the operating revenue of FINECURE PHARMACEUTICALS LIMITED?

    The operating revenue of FINECURE PHARMACEUTICALS LIMITED is in the range of INR 100 cr - 500 cr for the financial year ending on 31 March, 2023.

  • What is the change in EBITDA of FINECURE PHARMACEUTICALS LIMITED since last year?

    The EBITDA of FINECURE PHARMACEUTICALS LIMITED has decreased by -3.90 % over the previous year. At the same time, it's book networth has increased by 9.37 % for the financial year ending 31 March, 2023.

  • What is the business of FINECURE PHARMACEUTICALS LIMITED?

    The company is engaged in manufacturing of health care, personal care and home care products..

  • Which Products and Services are provided by FINECURE PHARMACEUTICALS LIMITED?

    The products and services offered by FINECURE PHARMACEUTICALS LIMITED are Pre And Pro Biotics, Enzyme Preparations, Proteolytics, Anti-allergics Or Anti-cold, Cough- Suppressants, Hormones, Emergency Contraceptives, Anti- Haemorrhagics, Sayfur Cv Oral Dry Syrup, Sayfur Cv 500 Tablets, Sayfur Cv 250 Tablets, AZOM DRY SYRUP etc..

  • Who are the directors of FINECURE PHARMACEUTICALS LIMITED?

    Finecure Pharmaceuticals Limited has six directors - Mukesh Tarachand Agarwal, Vivek Rajgarhia, and others.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more



Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More